Coya Therapeutics Ownership | Who Owns Coya Therapeutics?


OverviewForecastRevenueFinancialsChart

Coya Therapeutics Ownership Summary


Coya Therapeutics is owned by 27.89% institutional investors, 7.02% insiders, and 65.10% retail investors.

COYA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCoya Therapeutics27.89%7.02%65.10%
SectorHealthcare Stocks 279.20%10.62%-189.82%
IndustryBiotech Stocks 63.97%10.74%25.29%

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202526-4,662,5914.94%273.28%16-15.79%4-
Dec 31, 20242636.84%4,443,11234.02%296.15%19216.67%4-33.33%
Sep 30, 202419-3,315,1611.43%214.54%6-33.33%6-
Jun 30, 202419-3,268,292-2.12%214.11%9-30.77%6100.00%
Mar 31, 202419-9.52%3,339,07118.31%233.00%13-13.33%3-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 14, 2024SNYDER DAVID S Chief Financial OfficerBuy$12.93K
Nov 13, 2024Swaminathan Arun Chief Executive OfficerBuy$36.80K
Nov 11, 2024Grossman Fred Chief Medical OfficerBuy$19.97K
Nov 11, 2024Swaminathan Arun Chief Executive OfficerBuy$36.69K
Aug 22, 2023Lee Ann-Buy$3.62K

Insider Transactions Trends


DateBuySell
2025 Q1--
2024 Q44-
2024 Q3--
2024 Q2--
2024 Q1--

COYA Ownership FAQ


Who Owns Coya Therapeutics?

Coya Therapeutics shareholders are primarily institutional investors at 27.89%, followed by 7.02% insiders and 65.09% retail investors. The average institutional ownership in Coya Therapeutics's industry, Biotech Stocks , is 63.97%, which Coya Therapeutics falls below.

Does Blackrock own Coya Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Coya Therapeutics.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools